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a. Specific Aims 
 
 Pica is a condition characterized by the repetitive ingestion of non-food items for more 
than one month.  Due to the bizarre nature of this condition, pica has been studied and theorized 
over for many years.  It is most often found among children, the mentally ill, and pregnant 
women.  In regards to pica during pregnancy, the literature on pica covers the obviously 
detrimental effects on mothers of consuming clearly harmful substances.  Magnesium carbonate, 
more commonly referred to as chalk, is one of the most frequently ingested substances by 
women during pregnancy.  While often found within common brands of antacids, magnesium 
carbonate is frequently sold in block form and advertised as edible products within certain 
regions of the United States and Mexico.  The immediate effects of chalk ingestion upon a 
pregnant mother has been explored to some extent, but not to the degree in which the effects of 
clearly harmful substances have been examined.  A large gap is found in the literature when 
considering the effects of more benign substances such as magnesium carbonate not only on the 
mother, but the developing fetus as well.  More specifically, the current literature fails to address 
the question of whether magnesium carbonate ingestion during pregnancy could carry enduring, 
long-term effects for a fetus post-birth that could detrimentally influence later cognitive, motor, 
and/or behavioral development.   
 The following study strives to  investigate a possible relationship between the ingestion 
of magnesium carbonate during pregnancy and possible effects on the long-term health of 
infants born to pica practicing mothers.  The objective is to determine whether infants born to 
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mothers who ingest magnesium carbonate through pica practices are at a greater risk for a 
number of negative developmental abnormalities at birth and through the first 9 months of life.  
 
b. Background and Significance 
 
 As reviewed by Grigsby (1999), Bronstein found that pica is not an uncommon practice.  
While often associated with young children and the mentally ill, it has also been found to a 
significant degree in pregnant women.  This condition has often been explored in relation to 
potential nutritional deficiencies such as iron deficiency.  However, the context in which pica 
occurs, and the substance ingested, may point to additional driving factors such as cultural 
practices or obsessive compulsive disorders.  While not an uncommon condition, the rates of 
pica within the United States as a whole are relatively low.  A result of the widespread awareness 
of the condition across the United States is the perpetuation of a negative association with the 
practice.  As a whole, the United States displays rather low rates of pica, most likely because 
social pressures prevent individuals form indulging in their pica urges.  However, higher rates of 
ingestion of non nutritive substances are often found within specific populations. Grigsby (1999) 
explored the consumption of chalk in Georgia.  Through a series of interviews, it was found that 
20 of the 21 individuals  included within the study who reported regular chalk consumption were 
female. In addition, chalk consumption was deemed a culturally bound occurrence as each 
subject was of African American descent. The individuals who were interviewed for this study 
reported frequently that they had begun consuming chalk after it was suggested by a friend or 
relative. Although these findings are interesting, it is important to note that Grigsby conducted 
this study in an area that is predominantly African American, which may explain why each pica 
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practicing individual found was of this particular descent.     
 However, Simpson et al. (2000) also explored pica through a cultural lens.  The rates of 
pica were compared between towns in Mexico near the California border, and areas in Southern 
California.  Low-income women who were born in Mexico were recruited as subjects within this 
study.  Simpson found that magnesium carbonate was one of the most popular non-food items to 
ingest, and that some women even believed that consuming chalk would be beneficial for the 
fetus.  The rates of pica among both Mexican born women living in Mexico and those who were 
living in Southern California were both higher than the pica rate for the United States as a whole, 
44% and 31% respectively.  In addition, pica rates during pregnancy were significantly higher 
for the women still living in Mexico than those who had migrated to California (Simpson & 
Longeley, 2000).  This difference in pica rates was interpreted as indicating a strong cultural 
influence on consumption of non-food items during pregnancy such as magnesium carbonate.  It 
may be this cultural drive that encourages women to consume such substances as magnesium 
carbonate and potentially increase their child's risk of serious abnormalities at birth and beyond.  
 While the consumption of magnesium carbonate has been found to be greater in specific 
cultures, very little research has explored the effects that this practice may have on the 
developing child.  Nelson et al. (1971) found that magnesium carbonate was the main 
component of the antacids most frequently taken by pregnant women.  In addition, those women 
who ingested large amounts of antacids birthed infants who showed a higher rate of 
abnormalities within the 56 days post birth than mothers who did not consume any magnesium 
carbonate (Nelson & Forfar, 1971).  No further research on the effects of this particular 
compound was found.  The literature does, however, include a number of studies focused on 
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magnesium sulfate, a similar compound. 
 Magnesium sulphate is a substance that is often given to a pregnant woman when signs 
of pre-eclampsia are displayed.  Pre-eclampsia is a condition usually seen in the later trimesters 
where there is a marked increase in maternal blood pressure.  If this high blood pressure is not 
reduced, mothers are then susceptible to eclampsia, where the high blood pressure leads to 
seizures and dangerous pregnancy complications, such as possible coma or death.  The 
administration of magnesium sulfate has long been thought to reduce the risk of seizures, and 
therefore provide a better outcome for both mother and baby.  Witlin et al. (1998) reviewed all 
known investigations of magnesium sulfate therapy in pre-eclampsia and eclampsia.  It was 
concluded that throughout the literature, there does exist evidence to support the efficacy of 
magnesium sulfate treatment for pre-eclampsia and eclampsia. It was cautioned, however, that 
further research was required on the efficacy of this treatment to properly validate its increased 
usage (Witlin & Sibai, 1998). This caution grows from the lack of long term studies on the 
effects of magnesium sulfate not only on the mother, but on the developing infant as well.   
 The Magpie Trial Collaborate Group (2002) attempted such a validation. Women were 
recruited for this trial if they were experiencing pregnancy complications due to pre-eclampsia, 
and there existed doubt as to whether or not magnesium sulfate treatment was warranted.  
Participants were either administered magnesium sulfate or given a placebo.  The Magpie trial 
strove to investigate the effects of magnesium sulfate on both the mother and the child.  It was 
found that the women who had received magnesium sulfate had significantly fewer eclamptic 
convulsions, and lowered rates of maternal death.  However, this study is unique from those 
before it in that a number of negative maternal effects were recorded.  Those individuals within 
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the magnesium sulfate treatment condition exhibited a number of adverse physical side effects 
such as respiratory depression, respiratory arrest, pneumonia, cardiac arrest, coagulopathy, renal 
failure, haemorrhage, toxicity, vomiting, and weakness.  In addition to maternal complications, a 
number of fetal complications were reported as well.  A significantly greater incidence of 
induction, increased length of labor, and increased incidence of caesarean section was found 
among women treated with magnesium sulfate.  There was also a greater prevalence of retained 
placenta, blood loss, transfusion, neontal morbidity (Apgar < 7 at 5 min), incubation at place of 
delivery, ventilation, abnormal cerebral ultrasound, and convulsions (Magpie Collaborative 
Group, 2002).  While this study noted a number of maternal side effects of magnesium sulfate 
treatment in much greater detail than any studies that had come before, the focus on infants was 
very narrow in scope.  The researchers within this study were only interested in infant health 
through the day on which they were born.  There was not any follow up procedures enacted to 
further evaluate infant health in the following months.  A final conclusion on the effects of 
magnesium sulfate treatment on infants was not possible based on the data gathered through this 
study as the infants included were only followed until discharged from the hospital shortly after 
birth.   
 In addition to the risks of magnesium sulfate treatment on the fetus at the time of birth 
identified by the Magpie Trial Collaborate Group, Holcomb et al (1991) discovered an additional 
potentially harmful outcome, abnormal fetal bone mineralization.  Infants born to mothers who 
had undergone magnesium sulfate treatment for more than 7 days comprised the exposed group, 
while mothers who did not experience this particular treatment served as the control.  Infants 
born to non-exposed mothers showed no signs of bone abnormalities, while the majority of the 
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exposed group displayed definite abnormalities in the proximal humerus.  The abnormalities 
included discrete transverse metaphyseal radiolucent bands extending from just beneath the 
intact zones of provisional calcification, narrower sclerotic transverse band extending a variable 
distance through lucent metaphyseal lesion, and the thinning of the cortex at periphery of lucent 
bands (Holcomb et al., 1991) .  The main confound to this study however, was the very small 
subject pool, with a subject total of 33 infants.  Despite the small subject size, significant results 
were undoubtedly found.  It would be beneficial to re-create this study within a much larger 
subject pool to determine whether these results would still be significant within a larger 
population.  
   It is clear, then, that more research efforts have been applied to examining the effects of 
magnesium sulfate than magnesium carbonate.  While proven successful at reducing aspects of 
pre-eclampsia, magnesium sulfate was found to produce a number of negative side effects for 
both the mother and the fetus.  The following study strives to first address the gaps within the 
present literature by questioning whether these effects of magnesium sulfate treatment during 
pregnancy on both mother and fetus can be recreated.  If so, it then follows that perhaps maternal 
exposure to magnesium carbonate during pregnancy will produce similar results for infant health 
as magnesium sulfate, a similar compound, has been associated with.  Within the present 
literature, very little regard is given to the effects of magnesium carbonate exposure on the fetus, 
and on the infant post birth.  The proposed study will address the present shortcomings in the 
literature by not only assessing the effects of both magnesium sulfate and magnesium carbonate 
on the mother and child through birth, but also the possible longterm effects on the infant post 
birth.   
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c. Research Design and Methods  
 
I. Rationale 
 In order to investigate pica behavior among pregnant women, it would be most beneficial 
to carry out the proposed study in an area known to have higher pica rates than the nation as a 
whole.  As noted earlier, Simpson et al. (2000) compared pica rates in low-income Mexican born 
women in Mexico and in those who had moved to the United States and found especially high 
rates within both of these particular areas.  The proposed study will draw from her research by 
recruiting study participants from the same areas. Recruitment of pregnant women in Ensenada, 
Mexico, will be facilitated by a researcher's presence at the community clinic.  In addition, 
pregnant women will be recruited through researcher presence in outpatient clinics in Santa Ana, 
Bakersfield, and East Los Angeles.  The proposed study will focus on these two areas in hopes 
of discovering supportive evidence for pregnancy interventions.   
 Within these areas, and among Mexican-born women specifically, the dangers of 
ingesting non-food items during pregnancy are not clearly understood.  This lack of awareness is 
highlighted by the cultural influences that encourage women to ingest such items as magnesium 
carbonate to better the health of the fetus.  This misunderstanding and confusion regarding pica 
during pregnancy may be resulting in increased rates of abnormal births and abnormal infant 
development.  In order to ensure that individuals who practice pica will be found, the proposed 
study will recruit a number much larger than the final desired subject pool size.  It is possible to 
recruit subjects by asking for women who practice pica to sign up for the study, however, this 
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method may deter women from coming forward.  By presenting potential participants with a 
questionaire covering a range of topics, women will be more likely to give their consent for 
participation without being discouraged by a negative connotation associated with pica.  This 
study will be longitudinal in nature, following pregnant women not only through the time that 
their child is born, but beyond birth until the infant reaches 9 months of age.  Through this 
design, information can be gathered about infant health not only at the time of birth, but through 
the critical periods of development in the 9 months following.   
 
II. Methods 
 A number of exclusionary criterium will be taken into account when recruiting women 
from both the Mexican, and the California locations.  The researchers stationed at these various 
locations will approach possible candidates and inquire about the following qualifications.  
Participants who will be eligible to enroll in the study will be Mexican-born, and either still 
living in Mexico, or currently living in one of the Southern California locations.  The mother's 
primary language must be Spanish.  The women must be between the ages of 20-35 years and 
either pregnant, or planning to become pregnant shortly. Further qualifications include singleton 
birth, the mother's first pregnancy, and no other known pre-natal risks.  Furthermore, possible 
participants will be eliminated from the subject pool if they reported a history of cigarette, 
alcohol, or elicit drug use.  Mothers will also be eliminated if any serious, pre-existing maternal 
conditions are reported. Mothers must also be planning to give birth within a hospital setting as 
opposed to home birth or any other alternative birthing methods.  For those individuals who 
meet all qualifications, informed consent will be collected.   
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 Upon receiving informed consent from eligible study participants, a preliminary survey 
will be administered in a private room within the clinic from which they were recruited.  Ideally 
this preliminary survey will be completed on the same day of recruitment in order to reduce any 
inconvenience on the participant.  It will be available in Spanish. The questionaire will consist of 
a number of questions meant to asses the pica behavior of the participant.  If responding that pica 
behavior had been engaged in during pregnancy, the subject will have the opportunity to 
elaborate on the history of this behavior, as well as the particular features such as frequency and 
type of substance.  The mother's opinion on the dangers or benefits of consuming magnesium 
carbonate will also be probed.  In addition, the questionaire will also inquire whether the mother 
had experienced magnesium sulfate treatment lasting over 7 days during the pregnancy.    
 Upon completion of the survey, the researchers will place the women into one of three 
possible experimental groups.  The three conditions to be evaluated within the proposed study 
include pregnant women who have reported ingestion of magnesium carbonate during 
pregnancy, women who experienced more than 7 days of magnesium sulfate treatment during 
pregnancy, and a control group that neither ingested magnesium carbonate nor experienced 
magnesium sulfate treatment at any point throughout pregnancy.  There will be two sets of three 
groups, one set for Mexican-born women living in Mexico, and a set for Mexican-born women 
living in Southern California.  Those individuals who experienced more than 7 days of 
magnesium sulfate treatment and who also reported consuming magnesium carbonate during 
pregnancy will be excluded from the study.  Those women who reported ingesting a different 
non-food substance during pregnancy will also be excluded from the proposed study.  Due to the 
strict exclusionary criteria of the study, it will be necessary to recruit a large subject pool.  
Giselle Boulay    10 
Researchers will continue recruiting possible participants until 1,000 individuals have been 
found to comprise each of the three conditions for the two locations.  The recruitment of such a 
large subject pool will be difficult and time consuming, however over the duration of five years 
this recruitment goal will no doubt be a strong possibility.   
 The proposed study will utilize a longitudinal design to assess the health of infants born 
to women in each of the three conditions.  This design begins with light maternal monitoring 
throughout pregnancy.  After acceptance into the study, the pregnant women will be asked to 
complete and e-mail  a short questionaire to the researchers.  This will be designed to assess both 
current maternal and fetal health, pica frequency and timing, as well as details of any magnesium 
sulfate treatment.  This survey will be emailed, or mailed if no email is provided, to each 
participant at the end of each trimester.  If a participant was recruited at the beginning of their 
pregnancy, the most questionaires that a participant will be asked to complete while pregnant 
totals three. This questionaire will allow researchers to continually exclude mothers who no 
longer qualify, such as receiving magnesium sulfate treatment after reporting pica practices.   
 Whenever possible, a researcher will be present at the time of birth for the infants of 
women still eligible.  The participants will be instructed to inform the researchers when they are 
admitted to a hospital for labor.   In this case each infant will be given the Apgar test 1 minute 
post birth, and 5 minutes post birth.  In addition, within an hour post birth infants will be given a 
low-radiation x-ray to evaluate bone health.  A record of all women who require emergency 
induction or cesarean section will be gathered from the mothers by a self-report administered 
during a follow up call around the previously predicted due date. In any case possible, these 
infants will be given the same tests following birth as those birthed in normal conditions.  In 
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addition, a report of any major maternal or fetal complications during labor or post labor will be 
gathered, along with the number of maternal and/or infant deaths.     
 Upon discharge from the hospital post-birth, maternal and infant health will be monitored 
through a series of maternal reports and clinic visits. At ages 3, 6, and 9 months mothers will be 
asked to bring their infants to the clinic from which they were recruited for follow up tests.  At 
each of these visits, mothers will complete a questionaire assessing their magnesium carbonate 
ingestion practices post-pregnancy, and whether or not they are breastfeeding.  At each of these 
three visits, infants will complete the Bayley Scales of Infant Development (BIDS).  This test 
will be administered in order to measure the mental and motor development of infants, as well as 
assess their behavior at each age.  The scores received at each age will be recorded for later 
comparison.  Upon completing the questionaire and BIDS at each visit, mothers will be given a 
small amount of monetary compensation.   
 Once data has been collected from a total of 6,000 women and infants, a number of 
analyses will done.  The x-rays taken immediately following birth will be analyzed and 
categorized as normal or abnormal. A comparison will then be made between groups and across 
the two populations. The frequency and amount of magnesium carbonate ingested by mothers 
during pregnancy will be tabulated and compared between Mexican-born women living in 
Mexico and Mexican-born women living in California.  A similar comparison will be made 
between average length of magnesium sulfate treatment and average amount administered 
between the two locations.  The amount of labor complications and rates of maternal and infant 
mortality rates will also be found.  T-tests will be run to determine any significant differences 
between each of these location comparisons.  The average BIDS scores for infants in each of the 
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6 groups will be found and using an Anova compared within both populations and between both 
populations.  It will also be interesting to determine whether a mother's opinion on the risks or 
benefits for the fetus of consuming magnesium carbonate correlate with higher ingestion rates, 
and whether there is a significant opinion difference between the two studied locations.  
 
d. Predicted Results 
 Based on information found in the literature, it is hypothesized that both locations 
included within this study will have higher than normal rates of maternal pica during pregnancy.  
Magnesium carbonate will be a substance frequently ingested by pregnant women who report 
pica behaviors.  It is also predicted that infants born to women who ingested large amounts of 
magnesium carbonate or were treated for more than 7 days with magnesium sulfate will display 
abnormal developmental patterns.  Abnormalities may be seen immediately post-birth through 
the Apgar score or the chest x-rays.  In addition, the longitudinal design of this study will allow 
for possible abnormalities to be discovered through lower scores on the BIDS up until the age of 
9 months.  In addition, due to possible cultural effects, the rates of abnormalities may be greater 
for infants born to Mexican-born women living in Mexico. 
 While the proposed study should prove successful at pinpointing the effects of large-scale 
magnesium carbonate ingestion on the developing fetus and infant, there may be a number of 
limitations.  To begin, as pica habits are to be self-reported by the mothers, there may be an 
underreporting of pica.  Although the ingestion of magnesium carbonate appears to partially be a 
culturally encouraged behavior, there is also a widely known stigma against the condition. This 
negative connotation towards those who ingest non-food items may result in an underestimation 
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of how much magnesium carbonate is actually ingested during pregnancy.  In addition, the 
duration of magnesium sulfate treatment and amount administered was reported by the mothers 
as well, and therefore may not be entirely accurate.  Unknown drug usage could also affect the 
outcomes as it is difficult to ensure that a participant truly does not participate in any elicit drug 
use without the administration of periodic drug tests.  As the current study already involves a 
long duration time, this type of drug testing appears to be too taxing for the participants.  It may 
also be found that mothers are reticent to submit their infants to an x-ray post birth, no matter 
how safe the low-risk procedure may be.  It may be difficult then, to gather enough data 
regarding infant bone formation if mothers are less willing to participate in this aspect of the 
study.  
 An interesting follow up to the proposed study would be to examine whether there are 
developmental differences among infants who are breastfed by mothers who ingested large 
amounts of magnesium carbonate, mothers who experienced magnesium sulfate treatment, and 
mothers who did not experience either.  Whether or not exposure to these two substances may 
contaminate breast milk in some way, or harm maternal nutrition to such an extent that 
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